Adjunctive glucocorticoid therapy in patients with septic shock.
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Whether hydrocortisone reduces mortality among patients with septic shock is unclear. METHODS: We randomly assigned patients with septic shock who were undergoing mechanical ventilation to receive hydrocortisone (at a dose of 200 mg per day) or placebo for 7 days or until death or discharge from the intensive care unit (ICU), whichever came first. The primary outcome was death from any cause at 90 days. RESULTS: From March 2013 through April 2017, a total of 3800 patients underwent randomization. Status with respect to the primary outcome was ascertained in 3658 patients (1832 of whom had been assigned to the hydrocortisone group and 1826 to the placebo group). At 90 days, 511 patients (27.9%) in the hydrocortisone group and 526 (28.8%) in the placebo group had died (odds ratio, 0.95; 95% confidence interval [CI], 0.82 to 1.10; P=0.50). The effect of the trial regimen was similar in six prespecified subgroups. Patients who had been assigned to receive hydrocortisone had faster resolution of shock than those assigned to the placebo group (median duration, 3 days [interquartile range, 2 to 5] vs. 4 days [interquartile range, 2 to 9]; hazard ratio, 1.32; 95% CI, 1.23 to 1.41; P<0.001). Patients in the hydrocortisone group had a shorter duration of the initial episode of mechanical ventilation than those in the placebo group (median, 6 days [interquartile range, 3 to 18] vs. 7 days [interquartile range, 3 to 24]; hazard ratio, 1.13; 95% CI, 1.05 to 1.22; P<0.001), but taking into account episodes of recurrence of ventilation, there were no significant differences in the number of days alive and free from mechanical ventilation. Fewer patients in the hydrocortisone group than in the placebo group received a blood transfusion (37.0% vs. 41.7%; odds ratio, 0.82; 95% CI, 0.72 to 0.94; P=0.004). There were no significant between-group differences with respect to mortality at 28 days, the rate of recurrence of shock, the number of days alive and out of the ICU, the number of days alive and out of the hospital, the recurrence of mechanical ventilation, the rate of renal-replacement therapy, and the incidence of new-onset bacteremia or fungemia. CONCLUSIONS: Among patients with septic shock undergoing mechanical ventilation, a continuous infusion of hydrocortisone did not result in lower 90-day mortality than placebo. (Funded by the National Health and Medical Research Council of Australia and others; ADRENAL ClinicalTrials.gov number, NCT01448109 .).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Since then, three large RCTs have been published [354, 478, 479].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [479]
In the citing paper
“The optimal dose, timing of initiation, and duration of corticosteroids remain uncertain; recent RCTs used 200 mg per day of IV hydrocortisone in divided doses [354, 479].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [479]
In the citing paper
“The three trials [354, 478, 479] also used different inclusion criteria: in ADRENAL [479] eligible patients were those on any dose of vasopressor or inotrope for ≥ 4 h to maintain a MAP > 60 mmHg, and present at the time of randomisation.”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [479]
In the citing paper
“In the ADRENAL [479] study, hydrocortisone was administered for a maximum of seven days or until ICU discharge or death; in APROCCHSS [478] hydrocortisone was administered for seven days; in VANISH [354] 200 mg of hydrocortisone was administered daily for 5 days and then tapered over further 6 days.”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [479]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The third international consensus definitions for sepsis and septic shock (Sepsis-3).
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J.-D., Coopersmith, C. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0287 · Cited by 28,250
Self-citationA Simple Sequentially Rejective Multiple Test Procedure
(1979) · Scandinavian Journal of Statistics · doi:10.2307/4615733 · Cited by 21,526
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
Self-citationFleischmann, C., Scherag, A., Adhikari, N. K. J., Hartog, C. S., Tsaganos, T., Schlattmann, P., Angus, D. C., & Reinhart, K. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201504-0781oc · Cited by 3,548
Annane, D. (2002) · JAMA · doi:10.1001/jama.288.7.862 · Cited by 3,087
The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
Chrousos, G. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322008 · Cited by 2,579
Hydrocortisone Therapy for Patients with Septic Shock
Sprung, C. L., Annane, D., Keh, D., Moreno, R., Singer, M., Freivogel, K., Weiss, Y. G., Benbenishty, J., Kalenka, A., Forst, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa071366 · Cited by 2,132
Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014.
Rhee, C., Dantes, R., Epstein, L., Murphy, D. J., Seymour, C. W., Iwashyna, T. J., Kadri, S. S., Angus, D. C., Danner, R. L., Fiore, A. E., et al. (2017) · JAMA · doi:10.1001/jama.2017.13836 · Cited by 1,884
Cited by
Items 501–600 of 1,000
Glucocorticoid therapy for sepsis in the AI era: a survey on current and future approaches
Liang, C., Pan, S., Wu, W., Chen, F., Zhang, C., Zhou, C., Gao, Y., Ruan, X., Quan, S., Zhao, Q., et al. (2024) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2024.04.020 · Cited by 7
“Employing advanced machine learning methods and data from the CORTICUS trial [37], they confirmed the marker ’ s validity in three clinical cohorts.”
BackgroundMethodA Review of Current Evidence for the Use of Steroids in the Medical Intensive Care Unit
Jenkins, P., Cross, C., Abdo, T., Youness, H. A., & Keddissi, J. I. (2024) · Diagnostics · doi:10.3390/diagnostics14141565 · Cited by 9
“Venkatesh et al. randomized 3658 patients with septic shock requiring mechanical ventilation to 200 mg/day continuous infusion of hydrocortisone or placebo for 7 days [7].”
MethodBruyn, L. D., Téblick, A., Oudenhove, T. V., Perre, S. V., Derese, I., Pauwels, L., Derde, S., Vlieger, G. D., den Berghe, G. V., & Langouche, L. (2024) · Critical Care · doi:10.1186/s13054-024-05079-8 · Cited by 8
Song, B., Zheng, X., Fu, K., & Liu, C. (2024) · Medicine · doi:10.1097/md.0000000000040635 · Cited by 8
Hormone Therapy in Trauma Patients
Asehnoune, K., Vourc’h, M., & Roquilly, A. (2019) · Critical Care Clinics · doi:10.1016/j.ccc.2018.11.009 · Cited by 7
Kyriazopoulou, E., & Giamarellos‐Bourboulis, E. J. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1589451 · Cited by 7
“6% (p: NS) [52] Steroids RCT Hydrocortisone (1832) vs placebo (1826) 28-day mortality: 22.”
BackgroundBarakakis, P. A., Palaiodimos, L., Sosa, D. F., Benes, L., Gulani, P., & Fein, D. G. (2019) · Avicenna Journal of Medicine · doi:10.4103/ajm.ajm_97_19 · Cited by 7
“…corticosteroid treatment in critically ill patients with septic shock and activated protein C and corticosteroids for human septic shock trials, [6,27] especially with regard to their primary outcome, with the first failing and the latter succeeding in showing statistically significant 90-day…”
Li, J., Xie, M., Yu, Y., Tang, Z., Hang, C., & Li, C. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108660 · Cited by 7
Machado‐Alba, J. E., Usma-Valencia, A. F., Sánchez-Ramírez, N., Valladales‐Restrepo, L. F., Machado‐Duque, M. E., & Gaviria‐Mendoza, A. (2021) · Drugs - Real World Outcomes · doi:10.1007/s40801-021-00241-y · Cited by 7
“Varying results have been reported by different studies, especially in mechanically ventilated patients [29, 30].”
MethodResultMetabolic resuscitation in pediatric sepsis: a narrative review
Schlapbach, L. J., de Oliveira, C. F., Raman, S., & de Souza, D. (2021) · Translational Pediatrics · doi:10.21037/tp-21-1 · Cited by 9
“…in adult patients treated in ICU with septic shock have consistently demonstrated faster reversal of septic shock using treatment with hydrocortisone for at least 72 hours, and a good safety profile (adverse events associated with hydrocortisoneaffected only 1.1% of the trial participants) (33-35).”
InfluentialThompson, K., Young, P. J., Venkatesh, B., Cohen, J., Finfer, S. R., Grattan, S., Hammond, N. E., Jan, S., Li, Q., Tanna, G. L. D., et al. (2021) · Australian Critical Care · doi:10.1016/j.aucc.2021.05.006 · Cited by 8
Self-citationWang, K., Yin, L., Song, Y., Zhang, M., Lu, Y., & Wang, S. (2022) · Journal of Pharmacy Practice · doi:10.1177/08971900221097193 · Cited by 7
“The use of corticosteroids may have mortality benefits in critically ill patients with septic shock but the results are mixed.(8,9) In 2017, Marik et al(10) conducted a small before-after retrospective study that showed mortality benefit of using ascorbic acid, together with hydrocortisone and thiamine (HAT) compared…”
BackgroundRagoonanan, D., Tran, N., Modi, V., & Nickelsen, P. M. (2022) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxac169 · Cited by 8
Choi, K., Park, J. E., Kim, A., Hwang, S., Bae, J., Shin, T. G., & Kim, K. (2022) · Clinical and Experimental Emergency Medicine · doi:10.15441/ceem.22.276 · Cited by 7
The Timing of Initiating Hydrocortisone and Long-term Mortality in Septic Shock
Zhang, L., Gu, W., Huang, T., Lyu, J., & Yin, H. (2023) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000006516 · Cited by 9
Blythe, R. D., Cook, D., & Graves, N. (2018) · F1000Research · doi:10.12688/f1000research.14619.1 · Cited by 8
Reactivation of Latent Cytomegalovirus Infection after Major Surgery: Risk Factors and Outcomes
Gardiner, B. J., Herrick, K. W., Bailey, R. C., Chow, J. K. L., & Snydman, D. R. (2019) · Surgical Infections · doi:10.1089/sur.2018.245 · Cited by 7
“Whereas this has been demonstrated to have short-term physiologic benefits in patients with vasopressor-refractory hypotension, overall impact on long-term survival and risk of secondary infections is less clear [30–35].”
Clinical interventions for severe and critical COVID-19: what are the options.
Yuan, W., Liu, S., Lu, L., Feng, J., & He, X. (2020) · PubMed Central · Cited by 7
Adding vitamin C to hydrocortisone lacks benefit in septic shock: a historical cohort study
Chang, K. L., Harbin, M., Shuster, C., Griesdale, D. E. G., Foster, D., Sweet, D. D., Wood, M. D., & Dhingra, V. K. (2020) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-020-01814-1 · Cited by 7
Krieger, J. A., McGuire, F., Risa, E. L., Longino, A. A., Coppess, S. M., Riveros, T., Hebert, C., Town, J. A., Bhatraju, P. K., & Johnson, N. J. (2021) · Journal of the American College of Emergency Physicians Open · doi:10.1002/emp2.12350 · Cited by 7
Clinical Effect of Systemic Steroids in Patients with Cirrhosis and Septic Shock
Serafim, L. P., Simonetto, D. A., Anderson, A. L., Choi, D. H., Weister, T. J., Hanson, A. C., Kamath, P. S., Gajic, O., & de Moraes, A. G. (2021) · Shock · doi:10.1097/shk.0000000000001822 · Cited by 7
“This finding is in accordance with previous studies showing no difference in frequency or duration of renal-replacement therapy in the general population of patients with septic shock (22) and severe sepsis (23) receiving steroids.”
ResultInflammation, immunity and allergy
Stewart, D., & Nichol, A. (2021) · Anaesthesia & intensive care medicine · doi:10.1016/j.mpaic.2021.06.004 · Cited by 9
Cirrhosis Management in the Intensive Care Unit
Smith, T. N., de Moraes, A. G., & Simonetto, D. A. (2023) · Seminars in Liver Disease · doi:10.1055/a-2015-1290 · Cited by 8
Hydrocortisone Reduces 28-day Mortality in Septic Patients: A Systemic Review and Meta-analysis
Siddiqui, W. J., Iyer, P. S., Aftab, G. M., Zafrullah, F., Zain, M. A., Jethwani, K., Mazhar, R., Abdulsalam, U., Raza, A., Hanif, M. O., et al. (2019) · Cureus · doi:10.7759/cureus.4914 · Cited by 7
“This study was adequately powered to determine a mortality difference [13].”
BackgroundResultInfluentialRisk assessment, diagnosis, and treatment of cancer treatment-related adrenal insufficiency
Hayes, A. G., Rushworth, R. L., & Torpy, D. J. (2022) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2022.2023009 · Cited by 7
Schlapbach, L. J., Reinhart, K., & Kissoon, N. “. (2021) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00331.2021 · Cited by 7
Fluids or vasopressors for the initial resuscitation of septic shock
Macdonald, S., Peake, S. L., Corfield, A. R., & Delaney, A. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1069782 · Cited by 6
“Administration of glucocorticoids results in faster resolution of shock in ventilated intensive care (ICU) patients with sepsis, although there is no convincing evidence for a survival benefit with hydrocortisone alone (23).”
BackgroundJiang, M., Ye, X., Shi, D., Lin, Q., Huang, F., & Li, Y. (2023) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/168431 · Cited by 6
Venkatesh, B., Rey, D. A., Evans, D. M., Yao, L., Finfer, S. R., Bellomo, R., Silva, T. C., Cohen, J., Qiu, Y. L., Lucena, W. D. R., et al. (2025) · Critical Care and Resuscitation · doi:10.1016/j.ccrj.2025.100109 · Cited by 7
“3,4 These trials reported con fl icting effects on day-90 mortality but consistent improvements in the rate of shock reversal and weaning from mechanical ventilation.”
Self-citationCost-Effectiveness in Critical Care: A Systematic Review of Empirical Evaluations
Tatsis, F., Gouva, M., Dragioti, E., Veroniki, F., Stamatis, K., Παπαθανάκος, Γ., & Koulouras, V. P. (2025) · Healthcare · doi:10.3390/healthcare13212783 · Cited by 11
Bourdiol, A., & Roquilly, A. (2022) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0041-1740606 · Cited by 6
Colorectal Surgery in Critically Unwell Patients: A Multidisciplinary Approach
Subramaniam, A., Wengritzky, R., Skinner, S. A., & Shekar, K. (2022) · Clinics in Colon and Rectal Surgery · doi:10.1055/s-0041-1740045 · Cited by 7
Epidemiology of sepsis in a Japanese administrative database
Imaeda, T., Oami, T., Takahashi, N., Saito, D., Higashi, A., & Nakada, T. (2023) · Acute Medicine & Surgery · doi:10.1002/ams2.890 · Cited by 6
“Two large RCTs were published in 2018, one of which demonstrated no mortality benefit (ADRENAL trial), 50 while the other indicated a benefit in cases of greater severity (APROCCHSS trial).”
BackgroundStoiber, A., Hermann, A., Wanka, S.-T., Heinz, G., Speidl, W. S., Hengstenberg, C., Schellongowski, P., Staudinger, T., & Zilberszac, R. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13123505 · Cited by 6
“Even in some pure shock cohorts, the mortality rate was lower, such as 24% [20].”
BackgroundLi, Y., Wang, Y., Guo, J., & Zhang, D. (2024) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2024.05.001 · Cited by 6
Panwar, R., McNicholas, B., Niță, C., Gibberd, A. J., Poulter, A., Tauares, M., & Ferguson, L. (2025) · Journal of Intensive Care · doi:10.1186/s40560-025-00798-8 · Cited by 6
“This is consistent with data on achieved MAP reported in other major RCTs such as ADRENAL RCT [29] and the usual care group of the JAMA-65 trial [30].”
Immunoadsorption Techniques and Its Current Role in the Intensive Care Unit
Hamilton, P., Harris, R., & Mitra, S. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.84890 · Cited by 8
Endocrinopathy of the Critically Ill
Aerde, N. V., Dyck, L. V., Vanhorebeek, I., & den Berghe, G. V. (2019) · Lessons from the ICU · doi:10.1007/978-3-030-24250-3_9 · Cited by 6
Methimazole-Induced Agranulocytosis and Sepsis: was Thyroid Storm Present or Just Being Mimicked?
Stumpf, M. A. M. (2019) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2019.522 · Cited by 6
External validation of the sepsis severity score
Wełna, M., Adamik, B., Goździk, W., & Kübler, A. (2020) · International Journal of Immunopathology and Pharmacology · doi:10.1177/2058738420936386 · Cited by 6
Shah, A. M., Dave, S. B., Galvagno, S. M., George, K., Menne, A. R., Haase, D., McCormick, B. M., Rector, R. P., Dahi, S., Madathil, R. J., et al. (2021) · Membranes · doi:10.3390/membranes11050306 · Cited by 6
Sacha, G. L., Chen, A. Y., Palm, N. M., Wang, X., Li, M., & Duggal, A. (2022) · Journal of Pharmacy Practice · doi:10.1177/08971900211037589 · Cited by 6
“Recent studies have attempted to better elucidate which patient population may benefit from hydrocortisone; however, results remain inconsistent and data are still limited by variations in adjunctive interventions.(12,13) Regardless of the conflicting literature, current guidelines recommend that patients with septic…”
ResultEstrategia integral de reanimación del paciente con sepsis y shock séptico
del Río-Carbajo, L., Olmo, J. N.-D., Fernández‐Ugidos, P., & Vidal, P. (2022) · Medicina Intensiva · doi:10.1016/j.medin.2022.02.003 · Cited by 9
Ousaka, D., & Nishibori, M. (2022) · Folia Pharmacologica Japonica · doi:10.1254/fpj.22073 · Cited by 6
Arcellana, A. E., Lim, K. W., Arcegono, M., & Jimeno, C. (2022) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.038.01.02 · Cited by 6
Liu, Z., Chen, H., Tan, C., Zha, J., Liu, H., & Chen, G. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115551 · Cited by 6
Aokage, T., Iketani, M., Seya, M., Meng, Y., Ageta, K., Naito, H., Nakao, A., & Ohsawa, I. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112270 · Cited by 6
Dong, Y., Heng, G., Zhang, J., Shen, Y., Lan, Z., Wei, K., & Jin, W. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1276181 · Cited by 7
“Large-scale randomized trials published in 2018 showed that low-dose corticosteroids brought about benefits in terms of shock reversal and duration of mechanical ventilation support (11, 12).”
BackgroundA novel vital sign pattern predicts sepsis-related myocardial injury mortality
Liu, W., Dai, J., Zhang, P., Ni, M., Zhang, Y., Fang, H., & Zhang, Z. (2024) · iScience · doi:10.1016/j.isci.2024.110787 · Cited by 7
New York State Infection Control
Habboush, Y. Y., Benham, M. D., Louie, T., Noor, A., & Sprague, R. M. (2020) · StatPearls · Cited by 6
Hammond, N. E., Kumar, A., Vijayaraghavan, B. K. T., Arabi, Y. M., Cohen, J., Tanna, G. L. D., Grattan, S., van Heerden, V., Joynt, G. M., Machado, F. S., et al. (2021) · Critical Care and Resuscitation · doi:10.51893/2021.2.s1 · Cited by 7
Self-citationLiu, Y., Zhang, C., Li, C., Bai, C., & Shang, H. (2020) · Clinical Interventions in Aging · doi:10.2147/cia.s268140 · Cited by 6
Annane, D., Pirracchio, R., Billot, L., Waschka, A. K., Chevret, S., Cohen, J., Finfer, S. R., Gordon, A. C., Hammond, N. E., Myburgh, J., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-040931 · Cited by 6
Self-citationDonaldson, L., Hammond, N. E., Agarwal, S., Taylor, S., Bompoint, S., Coombes, J., Bennett‐Brook, K., Bellomo, R., Myburgh, J., & Venkatesh, B. (2022) · Critical Care and Resuscitation · doi:10.51893/2022.1.oa3 · Cited by 7
“…may have been contributed to by a relatively high 90-day mortality rate among the non-Indigenous cohort (37% [23/62]) — higher than that for the overall ADRENAL trial cohort (28.3% [1037/3658]) 13 — this difference in outcome remained significant after adjustment for several predictors of death.”
ResultInfluentialSelf-citationChen, F., Qu, F., Jia, Y., Wang, C., Yu, Y., Liao, J., Min, L., Chen, F., & Zhi-jia, S. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/1240242 · Cited by 7
“A clinical study has shown that steroids could stabilize hemodynamics and shorten the length of intensive care unit stay and duration of mechanical ventilation in patients with septic shock [61].”
BackgroundRomiti, G. F., Corica, B., Raparelli, V., Basili, S., & Cangemi, R. (2020) · Nutrients · doi:10.3390/nu12061550 · Cited by 7
“The immunomodulatory effect of steroids has been postulated, and their use in the setting of intensive care has been widely studied, with conflicting results [14,15].”
BackgroundWong, J. K. L., Thomas, C., Gravett, H., Thobhani, K., Mekhaimar, A., Wong, J. M., & Wan, Y. I. (2025) · BJA Open · doi:10.1016/j.bjao.2025.100425 · Cited by 7
“21 e 23,29,30,33,34 No other participant characteristics were stratified or adjusted for.”
Chang, W.-H., Yang, S.-H., Shen, H.-F., Hu, T.-Y., & Wu, W.-J. (2025) · Biomedicines · doi:10.3390/biomedicines13122904 · Cited by 5
Pathophysiology and Management of Sepsis-associated Acute Kidney Injury
Menon, S., Sanghavi, S. F., Neyra, J. A., & Bhatraju, P. K. (2026) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2025.11.007 · Cited by 5
Endothelial cell responses in sepsis are attenuated by targeting truncated procalcitonin
Brabenec, L., Hellenthal, K. E. M., Kintrup, S., Cyran, L., Burkard, P., Nottebaum, A. F., Schughart, K., Wagner, S., Arnold, R. R., Rauschenberger, V., et al. (2026) · Nature Communications · doi:10.1038/s41467-025-68199-x · Cited by 6
“So far, most therapeutic strategies failed to improve sepsis outcome 13,14 , including antagonizing IL-1 15 , TNFalpha 16 or application of hydrocortisone 17 .”
Li, J., Zhang, Y., Jiang, F., Shi, X., Tu, M., Liu, Z., & Ye, F. (2026) · Inflammation Research · doi:10.1007/s00011-025-02173-7 · Cited by 5
Badero, O. J., Omokore, O. A., Oore-ofe, O., Osibowale, B. T., Quadri, I. O., Olayinka, T. O., Olabode, D., Kalu, K. E., Adeyemi, A., Buari, M. O., et al. (2026) · Cureus · doi:10.7759/cureus.106312 · Cited by 6
“Corticosteroids remain widely studied, shortening shock duration and possibly reducing mortality in selected vasopressor-dependent patients [41,42].”
Wiss, A. L., Doepker, B. A., Hoyte, B., Olson, L. M., Disney, K. A., McLaughlin, E. M., Esguerra, V. G., & Elefritz, J. L. (2023) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2023.05.001 · Cited by 6
Wu, J., Liu, M., Liu, T., Huang, P., Restinia, M., Hsu, W., Tsai, Y., Chuang, M., Hung, K., & Lai, C. (2024) · Infection · doi:10.1007/s15010-024-02381-z · Cited by 13
“Some randomized clinical trials (RCTs), such as the VANISH [7] and ADRENAL trials [8], exclusively used hydrocortisone, whereas others utilized a combination of hydrocortisone and fludrocortisone [ 9–11].”
Deng, J., Bedri, N., Zuo, Q., Azab, M., Chang, O., Virdi, R., Hung, J., Venugopal, K., Tahir, U., & Heybati, K. (2024) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000004551 · Cited by 5
Li, J., LI, Z., Qian, J., Liao, W., & Xu, F. (2025) · Scientific Reports · doi:10.1038/s41598-025-99198-z · Cited by 6
“Administering low-dose, short-course glucocorticoids to septic shock patients can reduce the dosage of vasopressors needed and enhance the sensitivity of vascular smooth muscle to catecholamine receptors, thereby effectively correcting shock 15,16 .”
Beyond Fluid Therapy: The Role of Vitamin C, Steroids, and Thiamine in Sepsis Management
Idahor, C. O., Ogunfuwa, O., Ogbonna, N., Adigwe, A., & Ogbeide, O. A. (2025) · Cureus · doi:10.7759/cureus.84666 · Cited by 5
“…Ill Patients With Septic Shock (ADRENAL) trial, which focused on critically ill patients with septic shock, a continuous infusion of hydrocortisone in patients on mechanical ventilation did not lead to a significant decrease in mortality when compared to those receiving a placebo [87,88].”
Fujishima, S. (2025) · Journal of Intensive Care · doi:10.1186/s40560-025-00809-8 · Cited by 6
Chang, W.-H., Hu, T.-Y., & Kuo, L. (2025) · Life · doi:10.3390/life15081317 · Cited by 5
“Recent meta-analyses—including those by Chang et al., Fujii et al., and Suzuki et al.—further support the notion that any mortality benefit is limited to high-risk subgroups with early therapy and elevated endotoxin levels [10,11,20,24].”
Kido, K., Shindo, Y., Toda, S., & Masaki, E. (2018) · Annales d Endocrinologie · doi:10.1016/j.ando.2018.06.001 · Cited by 5
Vorhofflimmern bei nichtkardialen Infektionen und Sepsis
Rath, B., Niehues, P., Leitz, P. R., & Eckardt, L. (2019) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-019-0633-z · Cited by 5
Severe Sepsis: The Fragile Anatomy of Crude Mortality
Vissichelli, N. C., Sima, A. P., & Wenzel, R. P. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab677 · Cited by 5
How Would You Treat This Patient Hospitalized With Community-Acquired Pneumonia?
Kanjee, Z., Metlay, J. P., Moskowitz, A. L., & Reynolds, E. E. (2021) · Annals of Internal Medicine · doi:10.7326/m21-3650 · Cited by 5
Abrupt Discontinuation Versus Taper of Hydrocortisone in Patients With Septic Shock
Carabetta, S., Allen, B., Cannon, C., & Johnson, T. (2022) · Annals of Pharmacotherapy · doi:10.1177/10600280221117156 · Cited by 6
Lock, A. E., Gutierrez, G., Hand, E., Barthol, C. A., & Attridge, R. L. (2023) · Annals of Pharmacotherapy · doi:10.1177/10600280231164210 · Cited by 5
“13,14 This may be attributed to lower severity of illness, as evidenced by the lower SAPS II scores, rate of MV, and norepinephrine dose requirement in our patient population compared with the Ger-Inf-05 and APROCCHSS trials.”
BackgroundResultTyagi, A., Salhotra, R., Sharahudeen, A., Rautela, R. S., & Kemprai, R. (2024) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-24793 · Cited by 5
Sepsis-Diagnostik und empirische Therapie in der Notaufnahme
Fuchs, A., Pletz, M. W., & Kaasch, A. J. (2018) · Notfall + Rettungsmedizin · doi:10.1007/s10049-018-0472-1 · Cited by 6
“Durch den Einsatz von Glukokortikoiden im septischen Schock ist keine Reduktion der Sterblichkeit zu erzielen [20].”
BackgroundWhat are the next steps for vitamin C in sepsis?
Udy, A. A., Fujii, T., & Luethi, N. (2018) · Critical Care and Resuscitation · doi:10.1016/s1441-2772(23)00686-5 · Cited by 5
Cuidado de Alto Valor en Medicina Crítica
Ñamendys-Silva, S. A. (2019) · Medicina Crítica · doi:10.35366/87295 · Cited by 7
Role of steroids in critically-ill sepsis patients: a review article and literature to review
Mirza, M. M., Zafar, M., Siddiqui, M., Abbas, A., Nahas, J., Mirza, M., & Tauseef, A. (2021) · Journal of Community Hospital Internal Medicine Perspectives · doi:10.1080/20009666.2021.1964164 · Cited by 6
“episode of mechanical ventilation than did those who had been assigned to receive placebo [5].”
BackgroundMethodGao, Y. X., Xiong, X., Jiao, X., Yu, Y., Chi, J., Zhang, W., Chen, L., Li, S. C., & Gao, Q. (2022) · Aging · doi:10.18632/aging.203819 · Cited by 5
Is hemolysis a novel therapeutic target in COVID-19?
Ousaka, D., & Nishibori, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.956671 · Cited by 5
“Surprisingly, although corticosteroids, including dexamethasone, have long been used clinically for sepsis (mainly bacterial sepsis), the results of multiple trials have reported that efficacy of corticosteroids cannot be proven until now (43, 44).”
BackgroundToward Increased Understanding of the Steroid Controversy in Septic Shock
Russell, J. A., & Sevransky, J. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000004038 · Cited by 6
Was ist gesichert in der Therapie der Sepsis?
Stahl, K., Seeliger, B., David, S., & Schmidt, J. J. (2020) · Der Internist · doi:10.1007/s00108-020-00895-w · Cited by 7
Wu, Y., & Lauffenburger, J. C. (2020) · PLoS ONE · doi:10.1371/journal.pone.0243149 · Cited by 7
“, 1-day and 5-day, adjusting accordingly for immortal time bias); (3) comparing the treated to those receiving any dose of corticosteroids; (4) including daily hydrocortisoneequivalent corticosteroid doses within 200mg and 400mg as inclusion criterion to better mimic RCTs [4, 11]; (5) excluding control patients who re…”
MethodResultInfluentialA Novel Human Glucocorticoid Receptor Variant, G459V, is Hyperactive in Response to Steroids
Grigsby, M. J., Green, T. L., Lim, D., Cho, K., & Greenhalgh, D. G. (2021) · Shock · doi:10.1097/shk.0000000000001729 · Cited by 5
Running from a Bear: How We Teach Vasopressors, Adrenoreceptors, and Shock
Manson, D. K., Dzierba, A. L., Seitz, K. M., & Brodie, D. (2023) · ATS Scholar · doi:10.34197/ats-scholar.2021-0132ht · Cited by 6
Pharmacologic Agents for the Treatment of Vasodilatory Shock
Knotzer, H., Poidinger, B., & Kleinsasser, A. T. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190704101907 · Cited by 5
When and how to use predictive biomarkers for corticosteroid treatment of septic shock
Russell, J. A. (2018) · Critical Care · doi:10.1186/s13054-018-2254-z · Cited by 5
Fludrocortisone with hydrocortisone in sepsis: new evidence in an ongoing debate
Ranzani, O., Annane, D., & Singer, M. (2024) · Intensive Care Medicine · doi:10.1007/s00134-024-07699-8 · Cited by 5
“The ADRENAL trial randomized 3800 patients with septic shock undergoing mechanical ventilation, and reported no difference in 90-day mortality between hydrocortisone and placebo but faster resolution of shock [5].”
Dorin, R. I., Urban, F. K., Perogamvros, I., & Qualls, C. R. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac173 · Cited by 4
Rusev, S., Thon, P., Rahmel, T., Ziehe, D., Marko, B., Nowak, H., Ellger, B., Limper, U., Schwier, E., Henzler, D., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073871 · Cited by 5
Zhu, X., Xue, J., Maimaitituerxun, R., Liu, Y., Zhou, Q., Zhou, Q., Zhao, S., Xu, H., Xie, H. W., Dai, W., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-05515-x · Cited by 4
“Previous clinical trials and systematic reviews have evaluated the efficacy and safety of corticosteroids in septic patients, but the findings remain inconclusive 27–30 .”
Peter, J. V., Venkatesh, B., Premkumar, P. S., Binila Chacko, I., Gunasekaran, K., Krishna, B., Chaudhry, D., Saravu, K., Wyawahare, M., Ray, S., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-104171 · Cited by 6
“As with other studies such as the adjunctive corticosteroid treatment in critically ill patients with septic shock (ADRENAL) study, 33 randomised evaluation of normal versus augmented level of replacement (RENAL) study 34 and crystalloid versus hydroxyethyl starch (CHEST) study, 35 a formal and…”
Self-citationMultiple organ dysfunction syndrome: molecular mechanisms and therapeutic strategies
Xu, X., Chen, J., Feng, Y., Zou, C., Peng, X., Wang, Z., Ma, Y. X., Xie, Y., Li, H., & Zhang, D. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02782-6 · Cited by 6
“In septic shock, glucocorticoid administration shortens the duration of shock 382 but does not impact 90-day mortality.”
Liu, H., Hu, J., Xiao, J., Kang, H., & Zhou, F. (2022) · World Journal of Emergency Medicine · doi:10.5847/wjem.j.1920-8642.2022.095 · Cited by 5
Kulesza, S., Gignac, L., Colvin, C. A., Boll, S., Giuliano, C. A., Haan, B. J., Allen, B., Perez, M. M., Allen, M., & Edwin, S. B. (2023) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2811 · Cited by 4
Chatoor, R., Sekhar, P., Mahony, E., Nehme, E., Cox, S., Cudini, D., Shao, J., Smith, K. L., Anderson, D. J., Nehme, Z., et al. (2023) · Emergency Medicine Australasia · doi:10.1111/1742-6723.14357 · Cited by 4
“21,25,26 More speci fi cally, with a 6-month all-cause mortality rate greater than 20%, paramedics in Victoria were able to identify a cohort of patients at high-risk of poor longer-term outcomes, independent of existing comorbidity and physiological derangement.”
BackgroundAdjunctive Therapies in Acute Respiratory Distress Syndrome
Trieu, M., & Qadir, N. (2023) · Critical Care Clinics · doi:10.1016/j.ccc.2023.12.004 · Cited by 6
An overview of the recent trials of corticosteroids for severe community-acquired pneumonia
Edland, B., & WATERER, G. W. (2025) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2025.2513518 · Cited by 4
“The addition of fludrocortisone to glucocorticoids in the setting of septic shock appears to offer a small survival advantage [12], but glucocorticoids alone do not appear to offer significant benefit [13,14].”
Metadata
- Authors
- Venkatesh, B., Finfer, S., Cohen, J., Rajbhandari, D., Arabi, Y., Bellomo, R., Billot, L., Correa, M., Glass, P., Harward, M., Joyce, C., Li, Q., McArthur, C., Perner, A., Rhodes, A., Thompson, K., Webb, S., & Myburgh, J.
- Affiliations
- The University of Sydney (AU)
- From the George Institute for Global Health, University of New South Wales (B.V., S.F., D.R., L.B., M.C., P.G., M.H., Q.L., K.T., J.M.), St. George Clinical School, St. George Hospital (J.M.), Sydney Medical School, University of Sydney (B.V., S.F., J.M.), and Royal North Shore Hospital (S.F.), Sydney, the Princess Alexandra Hospital (B.V., C.J.) and Royal Brisbane and Women’s Hospital (J.C.), University of Queensland, and the Wesley Hospital (B.V., J.C.), Brisbane, Austin Hospital (R.B.), the...
- University of Copenhagen (DK)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2018-03
- Volume
- 378
- Issue
- 9
- Pages
- 797-808
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2784412824
- Cited by
- 1,037
- References
- 40
- Citations by year
- 2026: 111 · 2025: 122 · 2024: 90 · 2023: 106 · 2022: 110 · 2021: 121 · 2020: 149 · 2019: 135 · 2018: 91
- FWCI
- 96.74
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- Monash University Research Portal (Monash University) (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- St George's Online Research Archive (St George's University of London) (acceptedVersion)
- UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc-nd)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Research Repository (Kingston University London) (submittedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Funders
- National Health and Medical Research Council (1004108, 1124926)
- Health Research Council of New Zealand (12/206)
- National Institute of Health Research, United Kingdom
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Keywords
- septic shock, cortisol, mortality, mechanical ventilation, shock resolution, blood transfusion, intensive care unit, sepsis treatment, subgroup analysis, mechanical ventilation duration, vasopressor requirement, glycemic control
- MeSH terms
- Aged, Anti-Inflammatory Agents, Double-Blind Method, Female, Humans, Hydrocortisone, Infusions, Intravenous, Male, Middle Aged, Recurrence, Respiration, Artificial, Shock, Septic, Survival Rate, Fungemia, Bacteremia, Treatment Outcome, Chemotherapy, Adjuvant, Renal Replacement Therapy, APACHE
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.